(Q68852483)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

Good tolerance of weekly oral idarubicin: (4-demethoxydaunorubicin): a phase I study with pharmacology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

author name string

H Hochster

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

M Green

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

L Liebes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

J L Speyer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

J Wernz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

R Blum

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

28 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

297-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02897234

28 September 2019

exact match

0 references

cites work

Activity and distribution of iv and oral 4-demethoxydaunorubicin in murine experimental tumors

1 reference

12 December 2020

Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trial

1 reference

12 December 2020

Phase II clinical and pharmacological study of oral 4-demethoxydaunorubicin in advanced non-pretreated small cell lung cancer

1 reference

12 December 2020

Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study

1 reference

12 December 2020

Experimental evaluation of anthracycline analogs

1 reference

12 December 2020

Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferon.

1 reference

12 December 2020

A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma

1 reference

12 December 2020

Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers

1 reference

12 December 2020

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients

1 reference

12 December 2020

Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)

1 reference

12 December 2020

Synthesis, antitumor activity, and cardiac toxicity of new 4-demethoxyanthracyclines

1 reference

12 December 2020

Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses

1 reference

12 December 2020

4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study.

1 reference

12 December 2020

Clinical pharmacology of oral and intravenous 4-demethoxydaunorubicin

1 reference

12 December 2020

Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02897234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2369795%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference